Bridgebio Pharma, Inc. · NASDAQ:BBIO
Ellis Andrea sold 17,167 Bridgebio Pharma, Inc. shares (Form 4)
Traded Jul 9, 2026 · Filed Jul 13, 2026
On Jul 9, 2026, Ellis Andrea (Director) sold 17,167 Bridgebio Pharma, Inc. shares at US$84.00 for US$1.44M under a trading plan, leaving 22,579 shares. Filed Jul 13, 2026 (Form 4).
- Sold
- 17,167 shares
- Price
- US$84.00
- Value
- US$1.44M
- Holding after
- 22,579 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | Option exercise | 17,167 | US$16.75 | 39,746 | Direct |
| Jul 9, 2026 | Common Stock | Sale | 17,167 | US$84.00 | 22,579 | Direct |